• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.79% Nasdaq Up 0.16%

    Alkermes plc (ALKS)

    -NasdaqGS
    69.81 Up 0.81(1.17%) Jan 23, 4:00PM EST
    |After Hours : 69.75 Down 0.06 (0.09%) Jan 23, 6:36PM EST
    Add to Portfolio
    Prev Close:69.00
    Open:68.68
    Bid:N/A
    Ask:69.80 x 100
    1y Target Est:61.92
    Beta:1.83
    Next Earnings Date:N/A
    Day's Range:68.54 - 69.82
    52wk Range:38.49 - 71.17
    Volume:885,017
    Avg Vol (3m):1,051,690
    Market Cap:10.21B
    P/E (ttm):N/A
    EPS (ttm):-0.28
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ALKSUp 1.17%10.21B
    ABTDown 1.42%66.04B
    LLYDown 0.46%77.15B
    GSKUp 0.11%108.20B

    Key Statistics

    Forward P/E (1 yr):290.87
    P/S (ttm):17.43
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :0.27
    Quarterly EPS Est (Dec-14) :0.03
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):39.18

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alkermes Public Limited Company, an integrated biopharmaceutical company, develops medicines that enhance patient outcomes. The company offers RISPERDAL CONSTA for schizophrenia and bipolar I disorder; INVEGA SUSTENNA to treat schizophrenia; AMPYR... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback